Mark Baldry, Chief Commercial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 10,257 shares at $0.73 ($7K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Scheduled sale ($7k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XFOR | SELL | 2024-10-08 | $6K | — | Filing → |